CareDx (CDNA) EBIAT (2016 - 2025)
CareDx (CDNA) has disclosed EBIAT for 13 consecutive years, with -$4.1 million as the latest value for Q4 2025.
- Quarterly EBIAT fell 104.68% to -$4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$21.4 million through Dec 2025, down 140.64% year-over-year, with the annual reading at -$21.4 million for FY2025, 140.64% down from the prior year.
- EBIAT hit -$4.1 million in Q4 2025 for CareDx, down from $1.7 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $87.7 million in Q4 2024 to a low of -$118.1 million in Q4 2023.
- Historically, EBIAT has averaged -$13.3 million across 5 years, with a median of -$14.0 million in 2021.
- Biggest five-year swings in EBIAT: tumbled 2759.97% in 2022 and later skyrocketed 174.26% in 2024.
- Year by year, EBIAT stood at -$16.2 million in 2021, then fell by 13.49% to -$18.3 million in 2022, then plummeted by 544.32% to -$118.1 million in 2023, then surged by 174.26% to $87.7 million in 2024, then plummeted by 104.68% to -$4.1 million in 2025.
- Business Quant data shows EBIAT for CDNA at -$4.1 million in Q4 2025, $1.7 million in Q3 2025, and -$8.6 million in Q2 2025.